Updates on the Phase III Trial of Docetaxel versus Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (NCT03574571)
Joined April 2019
- Tweets165
- Following137
- Followers123
- Likes269
Brazil's Hospital de Amor de Barretos (Fundação Pio XII) is now enrolling patients onto @DoraTrial: A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer (NCT03574571) clinicaltrials.gov/study/NCT…
We are excited to announce Clinic de Barcelona 🇪🇸 and Instituto de Medicina Integral Professor Fernando Figueira (IMIP) 🇧🇷 have activated our phase 3 study to test radium-223 with docetaxel in patients with prostate cancer: clinicaltrials.gov/study/NCT…
¡Felicidades! Hospital Universitario Central de Asturias (HUCA) 🇪🇸 has randomized its first participant to DORA: A Phase 3 Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer clinicaltrials.gov/study/NCT…
Maasstad Ziekenhuis (🇳🇱) has enrolled its 200th participant to DORA! To learn more about this Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC) visit clinicaltrials.gov/study/NCT…
We are pleased to announce Instituto Brasileiro de Controle do Câncer (São Paulo) enrolled the first Brazilian participant to DORA: A Phase 3 Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer clinicaltrials.gov/study/NCT…
Marking an important milestone, @DoraTrial, A phase 3 study to test radium-223 with docetaxel (NCT03574571), randomized its 500th patient with prostate cancer today! clinicaltrials.gov/study/NCT…
🇪🇸 Three Spanish sites—Ramón y Cajal Hospital, Hospital Del Mar, Instituto Valenciano de Oncología—are now enrolling patients with advanced prostate cancer to DORA, the phase 3 study testing radium-223 with docetaxel 🇪🇸 More info: clinicaltrials.gov/study/NCT…
🇪🇸 Spain is the latest country to participate in @DoraTrial: A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer, with the addition of Barcelona's Hospital Del Mar 🇪🇸 classic.clinicaltrials.gov/c…
🇳🇱 We are excited to announce The Netherlands Cancer Institute (@NKI_nl) is now participating in our phase 3 study testing radium-223 with docetaxel in patients with #prostatecancer, under the local leadership of Dr Andre Bergman! For more info visit classic.clinicaltrials.gov/c…
A strong commitment between investigators, research professionals, patients, and advocates advances our search for improved standards of care.
The PCCTC-managed @DoraTrial (NCT03574571), a phase 3 study to test radium-223 with docetaxel in patients with #prostatecancer, is now 60% accrued. To learn more about this important trial for advanced disease visit pcctc.org/studies/dora/
The Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant #ProstateCancer (DORA) is now enrolling at 53 sites in the US and Netherlands. For more info visit pcctc.org/studies/dora/
DORATrial retweeted
@DoraTrial principal investigator Dr @morr316 discusses the aims, rationale and implications of the phase 3 prostate cancer study (NCT03574571): youtube.com/watch?v=Wu3gPuIM…
DORATrial retweeted
The PCCTC's phase 3 DORA trial (NCT03574571) of radium-223 with docetaxel in patients with #ProstateCancer
Combination treatment strategies with radium-223 for #mCRPC. @morr316 @MSKCancerCenter joins @CaPsurvivorship @DanaFarber to discuss the #DORA trial and how combinations of treatment can amplify the survival benefits seen with monotherapy approaches > bit.ly/3uQ60kj
DORA, The phase 3 #clinicaltrial of docetaxel vs. docetaxel and radium-223 for metastatic castration-resistant #prostatecancer is now enrolling at 53 sites in the US and Netherlands. For more info visit clinicaltrials.gov/ct2/show/…
From Stichting Dutch Uro-Oncology Studygroup (DUOS), "Investigators Meeting DORA met @morr316" 🇳🇱: stichtingduos.nl/investigato…
With the dedicated work of our Dutch research staff, clinicians, advocates, and patients we continue to make progress on this important #prostatecancer clinical trial.
Members of our @DoraTrial operations team recently visited the 🇳🇱 to meet with the Dutch site staff and investigators. Thanks to all for a wonderful and engaging meeting. Looking forward to our continued collaboration!
400 patients with #prostatecancer have now been randomized to the @DoraTrial. To learn more about this phase 3 study testing Radium-223 with docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC) visit: pcctc.org/studies/dora/
DORATrial retweeted
Congratulations to the DORA team @ThePCCTC and @morr316 for reaching this milestone. Study open to accrual at @UMassCancerCtr !
A message from Dr @morr316, @DoraTrial PI, on reaching the important milestone of 50% accrual: youtu.be/MJpQDXicyYo
A message from Dr @morr316, @DoraTrial PI, on reaching the important milestone of 50% accrual: youtu.be/MJpQDXicyYo
DORATrial retweeted
Great Article about @morr316 @SocietyofMSKCC - One of the most thoughtful researchers and clinicians in the field. There is more to come from this team! Triumph Against Prostate Cancer mskcc.org/annual-report/2021…